InvestorsHub Logo
Followers 73
Posts 2961
Boards Moderated 0
Alias Born 05/05/2004

Re: None

Wednesday, 09/11/2013 1:32:44 AM

Wednesday, September 11, 2013 1:32:44 AM

Post# of 40503
Has Anybody Noticed?

Kim must be one confident SOB... I thought he should've gotten more up front, however he did get one thing right and that's to have Roche pay for all expenses on the next two trials. Phase 3 trials can get mighty expensive. I have a feeling though that Roche only pays Inovio if phase test is successful.

Remember these two vaccines are best in class and Kim knows they'll be successful.

Roche has no therapies for hepatitis B in development, according to its official pipeline. This vaccine will be worldwide with Roche at the helm in a matter of weeks, once they are given the green light to market the vaccine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News